Treatment with the drug tocilizumab has been shown to reduce the risk of death among hospitalized patients with severe COVID-19.
Tocilizumab cuts the risk of death by about 30%, according to a study published Tuesday.
The medication, which also goes by the name Actmera is primarily used to treat rheumatoid arthritis.
The medication is an immunosuppressive drug designed to reduce inflammation.
